Accession Number: | 0001144204-19-017410 |
Date: | 2019-03-28 |
Issuer: | ANI PHARMACEUTICALS INC (ANIP) |
Original Submission Date: |
PRZYBYL ARTHUR
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE, MN 56623
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-03-28 | A | 37,280 | a | $0.00 | 242,356 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS | 66.39 | 2019-03-28 | deemed execution date | A | 45,106 (a) | 2029-03-27 | common stock 45,106 | $66.39 | 45,106 | direct |
ID | footnote |
---|---|
f1 | the restricted stock and stock options vest in four equal annual installments on the first, second, third and fourth anniversary of march 28, 2019. |